- Trials with a EudraCT protocol (1)
- Paediatric studies in scope of Art45 of the Paediatric Regulation (0)
1 result(s) found for: 2018-004800-20.
Displaying page 1 of 1.
EudraCT Number: 2018-004800-20 | Sponsor Protocol Number: MK-3475-937 | Start Date*: 2019-08-22 | |||||||||||
Sponsor Name:Merck Sharp & Dohme LLC., a subsidiary of Merck & Co., Inc. | |||||||||||||
Full Title: A Phase 3 Double-blinded, Two-arm Study to Evaluate the Safety and Efficacy of Pembrolizumab (MK-3475) versus Placebo as Adjuvant Therapy in Participants with Hepatocellular Carcinoma and Complete ... | |||||||||||||
Medical condition: Adjuvant treatment of HCC | |||||||||||||
|
|||||||||||||
Population Age: Adults, Elderly | Gender: Male, Female | ||||||||||||
Trial protocol: IE (Ongoing) SE (Ongoing) DE (Ongoing) NO (Ongoing) HU (Ongoing) PL (Ongoing) BE (Ongoing) DK (Ongoing) FR (Ongoing) ES (Ongoing) GB (GB - no longer in EU/EEA) IT (Ongoing) BG (Ongoing) | |||||||||||||
Trial results: (No results available) |
Subscribe to this Search
To subscribe to the RSS feed for this search click here
.
This will provide an RSS feed for clinical trials matching your search that have been added or updated in the last 7 days.
To subscribe to the RSS feed for this search click here

Download Options: | |
---|---|
Number of Trials to download: | |
Download Content: | |
Download Format: | |
Note, where multi-state trials are shown in search results, selecting "Full Trial details" will download full information for each of the member states/countries involved in the trial. |
